159
Views
18
CrossRef citations to date
0
Altmetric
Original

A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues

, , , , &
Pages 1608-1612 | Received 01 Aug 2005, Accepted 02 Nov 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Luca Laurenti, Francesco Autore, Idanna Innocenti, Barbara Vannata, Nicola Piccirillo, Federica Sorà, Domenico Speziale, Maurizio Pompili, Dimitar Efremov & Simona Sica. (2015) Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. Leukemia & Lymphoma 56:10, pages 2841-2846.
Read now
Münci Yağcı, Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Zeynep Akı, Gülsan Türköz Sucak & Rauf Haznedar. (2010) Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies. Hematology 15:4, pages 240-244.
Read now
Davide Rossi, Lisa Sala, Rosalba Minisini, Carlo Fabris, Edmondo Falleti, Michaela Cerri, Michela Emma Burlone, Pierluigi Toniutto, Gianluca Gaidano & Mario Pirisi. (2009) Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 50:4, pages 604-611.
Read now

Articles from other publishers (15)

Andry Van de Louw, Kathleen Twomey, Nicholas Habecker & Kevin Rakszawski. (2020) Prevalence of acute liver dysfunction and impact on outcome in critically ill patients with hematological malignancies: a single-center retrospective cohort study. Annals of Hematology 100:1, pages 229-237.
Crossref
Jorge Aguiar, José A Silva,Gerardo García,Gerardo Guillén,Julio C Aguilar. (2018) Cross-validation Studies of a Novel Low-cost Hepatitis B Virus Quantitative Polymerase Chain Reaction System. Euroasian Journal of Hepato-Gastroenterology 8:1, pages 38-41.
Crossref
Muhsin Kaya, Recai Akdogan, Feyzullah Uçmak, Mehmet O Ayyildiz, Abdullah Karakus & Muhammet A Kaplan. (2018) The Incidence and Predictive Factors in the Development of Acute Hepatitis in Patients with Leukemia. Euroasian Journal of Hepato-Gastroenterology 8:1, pages 31-37.
Crossref
José A. García-Marco, Julio Delgado, José A. Hernández-Rivas, Ángel Ramírez Payer, Javier Loscertales Pueyo, Isidro Jarque, Pau Abrisqueta, Pilar Giraldo, Rafael Martínez, Lucrecia Yáñez, Mª José Terol, Marcos González & Francesc Bosch. (2017) Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica. Medicina Clínica 148:8, pages 381.e1-381.e9.
Crossref
José A. García-Marco, Julio Delgado, José A. Hernández-Rivas, Ángel Ramírez Payer, Javier Loscertales Pueyo, Isidro Jarque, Pau Abrisqueta, Pilar Giraldo, Rafael Martínez, Lucrecia Yáñez, M. José Terol, Marcos González & Francesc Bosch. (2017) Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia. Medicina Clínica (English Edition) 148:8, pages 381.e1-381.e8.
Crossref
Ramin Yaghobi, Marjan Shaheli, Abbasali Rezaeian, Mahdiyar Iravani Saadi & Mani Ramzi. (2015) Study of the Associations Between TT Virus Single and Mixed Infections With Leukemia. Jundishapur Journal of Microbiology 8:4.
Crossref
Salvatore Zaffina, Valentina Marcellini, Anna Paola Santoro, Marco Scarsella, Vincenzo Camisa, Maria Rosaria Vinci, Anna Maria Musolino, Luciana Nicolosi, M. Manuela Rosado & Rita Carsetti. (2014) Repeated vaccinations do not improve specific immune defenses against Hepatitis B in non-responder health care workers. Vaccine 32:51, pages 6902-6910.
Crossref
Evangelista Sagnelli. (2014) Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World Journal of Hepatology 6:6, pages 384.
Crossref
José A. García Marco, Pilar Giraldo Castellano, Javier López Jiménez, Eduardo Ríos Herranz, José Luis Sastre Moral, M. José Terol Casterá & Francesc Bosch Albareda. (2013) Guía de consenso nacionales para el estudio y tratamiento de los pacientes con leucemia linfocítica crónica. Medicina Clínica 141:4, pages 175.e1-175.e8.
Crossref
Nicola Coppola, Gilda Tonziello, Mariantonietta Pisaturo, Vincenzo Messina, Salvatore Guastafierro, Marco Fiore, Valentina Iodice, Caterina Sagnelli, Maria Stanzione, Nicolina Capoluongo, Giuseppe Pasquale & Evangelista Sagnelli. (2011) Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. Journal of Medical Virology 83:11, pages 1909-1916.
Crossref
P. Borentain, P. Colson, D. Coso, E. Bories, A. Charbonnier, A. M. Stoppa, T. Auran, A. Loundou, A. Motte, E. Ressiot, E. Norguet, C. Chabannon, R. Bouabdallah, C. Tamalet & R. Gérolami. (2010) Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer. Journal of Viral Hepatitis 17:11, pages 807-815.
Crossref
Kadir Acar, Mevlüt Hakan Göktepe, İlker Polat & Hüseyin Atalay. (2010) Hepatitis B Reactivation with Fulminant Hepatitis During Rituximab Chemotherapy in a Patient with Follicular Lymphoma. Electronic Journal of General Medicine 7:1, pages 92-93.
Crossref
Michael HallekBruce D. ChesonDaniel CatovskyFederico Caligaris-CappioGuillaume DighieroHartmut DöhnerPeter HillmenMichael J. KeatingEmili MontserratKanti R. Rai & Thomas J. Kipps. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines. Blood 111:12, pages 5446-5456.
Crossref
Holbrook E. Kohrt, Daniel L. Ouyang & Emmet B. Keeffe. (2007) Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection. Clinics in Liver Disease 11:4, pages 965-991.
Crossref
Münci Yağcı, Kadir Acar, Gülsan Türköz Sucak, Kadri Yamaç & Rauf Haznedar. (2007) Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant. European Journal of Haematology 79:4, pages 292-296.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.